Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Merayo-Chalico

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Modern Rheumatology Case Reports|May 10, 2021
Lupus anticoagulant-hypoprothrombinaemia syndrome: subdural haematoma as an unusual and initial manifestationAmaya Llorente-Chávez, Juan Francisco Plascencia-Félix, Javier Merayo-Chalico
Rheumatology (Oxford, England)|September 24, 2015
Risk factors for systemic lupus erythematosus flares in patients with end-stage renal disease: a case-control studyAna Barrera-Vargas, Mariana Quintanar-Martínez, Javier Merayo-Chalico, et al.
The Journal of Rheumatology|June 3, 2014
Risk factors for drug-resistant bloodstream infections in patients with systemic lupus erythematosusAna Barrera-Vargas, Diana Gómez-Martín, Javier Merayo-Chalico, et al.
The Journal of Arthroplasty|July 16, 2017
Total Hip Arthroplasty Outcomes: An 18-Year Experience in a Single Center: Is Systemic Lupus Erythematosus a Potential Risk Factor for Adverse Outcomes?Javier Merayo-Chalico, Marco Gónzalez-Contreras, Rigoberto Ortíz-Hernández, et al.
Human Immunology|June 26, 2016
Lymphopenia and autoimmunity: A double-edged swordJavier Merayo-Chalico, Sandra Rajme-López, Ana Barrera-Vargas, et al.
Archives of Medical Research|October 15, 2021
Rheumatological Adverse Events of Cancer Therapy with Immune Checkpoint InhibitorsLilian Guadalupe Cano-Cruz, Ana Barrera-Vargas, Abigail Mateos-Soria, et al.
Rheumatology International|February 22, 2023
Patient-reported outcomes in ANCA-associated vasculitis: a cross-sectional study to explore the interactions between patients' and physicians' perspectivesJosé Joel Hurtado-Arias, Isabela Ramírez-Mulhern, Carlos Gonzalez-Martínez, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|May 15, 2025
A Novel Scoring System for Diagnosing Systemic Lupus Erythematosus-Related Cytopenias: Insights From a Cohort StudySamuel Govea-Peláez, Jonathan Campos-Guzmán, Roberta Demichelis-Gómez, et al.
Scientific Reports|June 20, 2024
A cross sectional study assessing steatotic liver disease in patients with systemic lupus erythematosusArmando Antonio Baeza-Zapata, Ashuin Kammar-García, Ana Barrera-Vargas, et al.
Clinical and Experimental Rheumatology|June 24, 2020
Toenail abnormalities in rheumatoid arthritis patients are associated with radiographic damage and impact disability: a cross sectional study nested within a cohortGabriela Sánchez-Cárdenas, Irazú Contreras-Yáñez, Silvia Méndez-Flores, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Modern Rheumatology Case Reports|May 10, 2021
Lupus anticoagulant-hypoprothrombinaemia syndrome: subdural haematoma as an unusual and initial manifestationAmaya Llorente-Chávez, Juan Francisco Plascencia-Félix, Javier Merayo-Chalico
Rheumatology (Oxford, England)|September 24, 2015
Risk factors for systemic lupus erythematosus flares in patients with end-stage renal disease: a case-control studyAna Barrera-Vargas, Mariana Quintanar-Martínez, Javier Merayo-Chalico, et al.
The Journal of Rheumatology|June 3, 2014
Risk factors for drug-resistant bloodstream infections in patients with systemic lupus erythematosusAna Barrera-Vargas, Diana Gómez-Martín, Javier Merayo-Chalico, et al.
The Journal of Arthroplasty|July 16, 2017
Total Hip Arthroplasty Outcomes: An 18-Year Experience in a Single Center: Is Systemic Lupus Erythematosus a Potential Risk Factor for Adverse Outcomes?Javier Merayo-Chalico, Marco Gónzalez-Contreras, Rigoberto Ortíz-Hernández, et al.
Human Immunology|June 26, 2016
Lymphopenia and autoimmunity: A double-edged swordJavier Merayo-Chalico, Sandra Rajme-López, Ana Barrera-Vargas, et al.
Archives of Medical Research|October 15, 2021
Rheumatological Adverse Events of Cancer Therapy with Immune Checkpoint InhibitorsLilian Guadalupe Cano-Cruz, Ana Barrera-Vargas, Abigail Mateos-Soria, et al.
Rheumatology International|February 22, 2023
Patient-reported outcomes in ANCA-associated vasculitis: a cross-sectional study to explore the interactions between patients' and physicians' perspectivesJosé Joel Hurtado-Arias, Isabela Ramírez-Mulhern, Carlos Gonzalez-Martínez, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|May 15, 2025
A Novel Scoring System for Diagnosing Systemic Lupus Erythematosus-Related Cytopenias: Insights From a Cohort StudySamuel Govea-Peláez, Jonathan Campos-Guzmán, Roberta Demichelis-Gómez, et al.
Scientific Reports|June 20, 2024
A cross sectional study assessing steatotic liver disease in patients with systemic lupus erythematosusArmando Antonio Baeza-Zapata, Ashuin Kammar-García, Ana Barrera-Vargas, et al.
Clinical and Experimental Rheumatology|June 24, 2020
Toenail abnormalities in rheumatoid arthritis patients are associated with radiographic damage and impact disability: a cross sectional study nested within a cohortGabriela Sánchez-Cárdenas, Irazú Contreras-Yáñez, Silvia Méndez-Flores, et al.
Pageof 5